Companies / Theriva Biologics, Inc. / Activity
Activity — Theriva Biologics, Inc.
4 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Wolf Jeffrey Alan Director | Grant | Stock Options (right to buy) | — | +75K | 75,000 0.16% of shares | low |
| Jan 5, 2026 | Kraws Jeffrey J Director | Grant | Stock Options (right to buy) | — | +75K | 75,000 0.16% of shares | low |
| Jan 5, 2026 | Shallcross Steven a CEO | Grant | Stock Options (right to buy) | — | +475K | 475,000 1.04% of shares | low |
| Jan 5, 2026 | Monahan John J Director | Grant | Stock Options (right to buy) | — | +75K | 75,000 0.16% of shares | low |